| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥6357.1B | ¥6035.9B | +5.3% |
| Operating Income | ¥365.4B | ¥348.2B | +4.9% |
| Ordinary Income | ¥362.0B | ¥343.5B | +5.4% |
| Net Income | ¥242.3B | ¥238.3B | +1.7% |
| ROE | 8.7% | 8.8% | - |
FY2026 Q3 cumulative results show steady growth with Revenue of 635.7B yen (YoY +5.3%), Operating Income of 36.5B yen (YoY +4.9%), Ordinary Income of 36.2B yen (YoY +5.4%), and Net Income of 24.2B yen (YoY +1.7%). Both drugstore and discount store segments contributed to top-line expansion, with operating margin maintained at 5.7%. The company demonstrates conservative capital structure with Debt/Capital ratio of 13.6% and equity ratio of 59.3%, though inventory turnover days of 85 days indicates potential working capital efficiency challenges. The deceleration in net income growth (+1.7%) relative to revenue growth (+5.3%) warrants attention regarding cost structure optimization.
Revenue increased 32.1B yen (+5.3%) driven by balanced growth across both operating segments. DrugStore segment external sales reached 361.1B yen while DiscountStore segment achieved 274.6B yen in external sales. Gross profit margin stood at 25.6%, maintaining stable merchandise mix profitability. Operating income expanded 1.7B yen (+4.9%) to 36.5B yen, with SG&A expenses at 126.4B yen representing 19.9% of revenue. The profit growth lagged revenue growth by 0.4 percentage points, suggesting modest operating leverage limitations. Ordinary income grew 1.8B yen (+5.4%) to 36.2B yen, slightly outpacing operating income due to non-operating income contributions. However, net income growth decelerated significantly to +1.7%, primarily attributable to increased tax burden as profit before tax grew +4.7% while net income growth lagged substantially. The tax burden coefficient (Net Income/EBT) of 0.674 indicates approximately 32.6% effective tax rate, compressing bottom-line profitability. Special losses of 0.4B yen including impairment losses of 0.1B yen were recorded as non-recurring factors but remained immaterial. This represents a "revenue up, profit up but decelerating" pattern, where top-line momentum is partially absorbed by tax effects and limited operational leverage.
The DrugStore segment recorded revenue of 407.2B yen with operating income of 21.3B yen, representing an operating margin of 5.2%. External customer sales of 361.1B yen increased from the prior year, establishing this as the core business representing approximately 56.8% of external sales. The DiscountStore segment achieved revenue of 274.6B yen with operating income of 15.3B yen, delivering a superior operating margin of 5.6%. Despite smaller scale at 43.2% of external sales, the DiscountStore segment demonstrates 0.4 percentage points higher profitability margin, suggesting stronger pricing power or cost efficiency in this format. Operating income growth was 0.1B yen (+0.6%) for DrugStore and 1.6B yen (+11.7%) for DiscountStore, indicating the DiscountStore segment as the primary driver of incremental profit expansion despite its smaller revenue base.
[Profitability] ROE of 8.7% reflects moderate shareholder return efficiency, decomposed into net profit margin of 3.8%, asset turnover of 1.352, and financial leverage of 1.69 under DuPont 3-factor analysis, with asset turnover serving as the primary ROE driver. Operating margin of 5.7% represents stable profitability within the retail sector context. [Cash Quality] Cash and deposits stood at 700.2B yen, providing short-term debt coverage of 28.0 times against short-term loans of 25.0B yen, indicating substantial liquidity reserves. However, cash flow statement data is unavailable in quarterly reporting, limiting assessment of operating cash generation quality. [Investment Efficiency] Asset turnover of 1.352 demonstrates effective revenue generation from asset base. Inventory turnover days of 85 days indicates slower-than-optimal working capital velocity, with inventories of 1,106.9B yen representing 23.5% of total assets. [Financial Health] Equity ratio of 59.3% provides solid capital foundation, current ratio of 172.4% indicates strong short-term liquidity, and debt-to-equity ratio of 0.16 reflects conservative leverage policy with total interest-bearing debt of 439.7B yen comprising only 9.4% of total assets.
Cash and deposits increased 96.3B yen YoY to 700.2B yen, representing 14.9% of total assets and demonstrating substantial cash accumulation alongside operating profit growth. Working capital composition shows inventories expanded 12.3B yen to 1,106.9B yen, reflecting business scale expansion but also contributing to the elevated 85-day inventory turnover period. Current assets increased 213.8B yen to 2,376.1B yen, driven primarily by cash accumulation and inventory build. On the liability side, accounts payable and accrued expenses within current liabilities increased 61.8B yen to 1,378.0B yen, suggesting effective supplier credit utilization to fund operations. Notably, short-term loans increased 15.0B yen (+150%) from 10.0B yen to 25.0B yen, indicating a shift in financing structure that warrants monitoring regarding refinancing patterns or seasonal working capital needs. Long-term debt of 414.6B yen remained relatively stable. The cash coverage ratio of short-term liabilities stands at 0.51, while cash plus receivables coverage reaches 0.81, indicating adequate but not excessive near-term liquidity when excluding inventory conversion requirements. The balance sheet movements suggest cash generation from operations has been sufficient to support both working capital expansion and maintain strong liquidity positioning.
Ordinary income of 36.2B yen versus operating income of 36.5B yen shows a modest non-operating net deduction of approximately 0.3B yen, indicating core operating performance drives substantially all earnings. Non-operating income structure comprises interest expense of 0.3B yen partially offset by non-operating income, resulting in marginal net drag. Non-operating items represent less than 0.1% of revenue, confirming earnings composition is overwhelmingly driven by core retail operations rather than financial or non-recurring gains. The interest burden ratio (Ordinary Income/Operating Income) of 0.984 demonstrates minimal financial cost impact on profitability. Special losses totaling 0.4B yen including impairment charges of 0.1B yen were recorded but represent only 0.1% of revenue, classified as immaterial non-recurring factors. The 10.0 percentage point gap between operating income growth (+4.9%) and net income growth (+1.7%) stems primarily from increased tax burden rather than operating or non-operating deterioration, as profit before tax grew +4.7% while effective taxation compressed net results. While operating cash flow data is unavailable to confirm cash-backed earnings quality, the substantial increase in cash holdings (+96.3B yen) alongside profit growth provides circumstantial evidence of cash generation, though inventory accumulation (+12.3B yen) suggests some working capital absorption.
Full-year guidance projects Revenue of 850.0B yen (YoY +6.0%), Operating Income of 47.3B yen (YoY +6.3%), and Ordinary Income of 46.0B yen (YoY +4.9%). Q3 cumulative progress rates against full-year targets stand at 74.8% for revenue, 77.3% for operating income, and 78.7% for ordinary income. These progress rates indicate performance tracking slightly above the standard 75% benchmark expected at Q3, suggesting potential for guidance achievement or modest upside. Operating income progress of 77.3% outpacing revenue progress of 74.8% by 2.5 percentage points indicates stronger-than-linear profit accumulation in the first nine months, reflecting operational leverage or cost management discipline. The company forecasts full-year EPS of 271.03 yen against Q3 cumulative actual of 207.15 yen, implying Q4 EPS contribution of approximately 63.88 yen. No mid-year guidance revisions were disclosed, indicating management maintains confidence in achieving original targets.
The company forecasts annual dividend of 66.00 yen per share for the full fiscal year. Based on Q3 cumulative net income of 242.3B yen and average shares outstanding of 116,977K shares, the implied payout ratio calculates to approximately 64.0% using the forecasted dividend against trailing net income. This represents an elevated payout level relative to typical corporate retention policies, though it remains within sustainable range given the company's cash position of 700.2B yen and conservative debt structure. No share buyback activity was disclosed in the available data. The total return ratio therefore equals the payout ratio of 64.0%, as shareholder returns are currently delivered exclusively through dividends. The absence of cash flow statement data limits assessment of dividend coverage by free cash flow, though the substantial cash balance and minimal debt burden provide circumstantial support for dividend sustainability.
Inventory management efficiency presents material risk, with inventory turnover days of 85 days substantially elevated and inventories comprising 23.5% of total assets (1,106.9B yen). This velocity indicator signals potential markdowns, obsolescence risk, or working capital drag that could compress margins if clearance activity accelerates. Competitive pricing pressure in both drugstore and discount retail formats poses ongoing margin risk, particularly as operating margin of 5.7% provides limited buffer against promotional intensity or category deflation. Short-term borrowing structure exhibits notable shift with short-term loans increasing 15.0B yen (+150%) from 10.0B yen to 25.0B yen, suggesting potential refinancing requirements or seasonal working capital financing patterns that introduce refinancing risk if credit conditions tighten or seasonal demand projections prove optimistic.
[Industry Position] (Reference - Proprietary Analysis) The company demonstrates superior profitability positioning within the retail sector. ROE of 8.7% significantly exceeds industry median of 2.9% (IQR: 0.5%-7.4%, n=16), ranking in the upper quartile for shareholder return efficiency. Operating margin of 5.7% surpasses industry median of 3.9% (IQR: 1.2%-8.9%), confirming above-average operational profitability despite competitive retail environment. Net profit margin of 3.8% substantially exceeds industry median of 2.2% (IQR: 0.2%-5.7%), indicating effective cost structure management. Revenue growth of 5.3% outpaces industry median of 3.0% (IQR: -0.1%-9.2%), demonstrating above-median market share capture or category expansion. Equity ratio of 59.3% aligns closely with industry median of 56.8% (IQR: 39.2%-64.5%), reflecting industry-typical capital structure conservatism. Current ratio of 1.72x falls below industry median of 1.93x (IQR: 1.48x-2.73x), though remains within healthy range. Asset turnover of 1.352 exceeds industry median of 0.95 (IQR: 0.77-1.16), highlighting superior asset utilization efficiency. Inventory turnover days of 85 compares favorably to industry median of 95.93 days (IQR: 25.57-122.58), indicating competitive but not exceptional inventory velocity. The company's profitability metrics consistently exceed industry benchmarks while maintaining comparable financial health indicators, positioning it as an above-average performer within the retail sector peer group. (Industry: Retail, N=16 companies, Comparison: FY2025-Q3, Source: Proprietary analysis)
The company exhibits balanced growth profile with revenue expansion (+5.3%) exceeding industry median (+3.0%) while maintaining superior profitability margins across operating (5.7% vs 3.9% median), net (3.8% vs 2.2% median), and ROE (8.7% vs 2.9% median) dimensions, indicating sustainable competitive positioning within retail sector. The DiscountStore segment demonstrates emerging profit growth driver characteristics with operating income expansion of +11.7% despite representing smaller revenue share, suggesting potential strategic emphasis opportunity to enhance consolidated profit growth trajectory. Working capital efficiency presents improvement opportunity, as inventory turnover days of 85 and total working capital of 998.1B yen suggest capital deployment optimization could unlock incremental returns, particularly given the +12.3B yen YoY inventory increase outpacing revenue growth on a relative basis.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.